33. Freeman, S., et al., The * bystander effect tumor regression when a fraction of the tumor mass 
is genetically modified. Cancer Res., 1993. 53: p. 5274-5283. 
34. Rubin, B.A. and L.B. Rorke, Adenovirus Vaccines, in Vaccines, S.A. Plotkin and E.A. Mortimer, 
Editor. 1994, W.B. Saunders: Philadelphia, p. 474-502. 
35. Rorke, L.B., B.A. Rubin, and J. Myers, Neurovirulence of adenoviruses. J. Neuropathol. Exp. 
Neurol., 1973. 32: p. 161-162. 
36. Akli, S., et al., Transfer of a foreign gene into the brain using adenovirus vectors. Nature 
Genetics, 1993. 3: p. 224-228. 
37. Le Gal La Salle, G., et al., An adenovirus vector for gene transfer into neurons and glia in the 
brain. Science, 1993. 259: p. 988-990. 
38. Bajocchi, G., S.H. Feldman, and R.G. Crystal, Direct in vivo gene transfer to ependymal cells in 
the central nervous system using recombinant adenovirus vectors. Nature Genetics, 1993. 3: p. 229- 
234 . 
39. Davidson, B.L., et al., A model system for in vivo gene transfer into the central nervous system 
using an adenoviral vector. Nature Genetics, 1993. 3: p. 219-223. 
40. Kim, B., et al., Assessment of efficacy of ganciclovir toxicity following adenovirus mediated gene 
transfer of the herpes simplex virus type I thymidine kinase gene to experimental intracrainial gliomas 
using 1 H MRS and MRI. in press, 1994. , 
41. Zabner, J., et al., Adenovirus-mediated gene transfer transiently corrects the chloride transport 
defect in nasal epithelia of patients with cystic fibrosis. Cell, 1993. 75: p. 207-216. 
42. Simon, R.H., et al., Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman 
primates: toxicity study. Human Gene Therapy, 1993. 4: p. 771-780. 
43. Aronen, H.J., et al., Cerebral blood volume maps of gliomas: comparison with tumor grade and 
histiologic findings. Radiology, 1994. 191: p. 41-51. 
44. Alavi, J., et al., Positron emission tomography in patients with glioma. Cancer, 1988. 62: p. 
1074-78. 
45. Patronas, N.J., et al., [18F] Fluorodeoxyglucose and positron emission tomography in the 
evaluation of radiation necrosis of the brain. Radiology, 1992. 144: p. 885-889. 
46. Abe, Y., T. Matsuzawa, and T. Fujiwara, Clinical assessment of therapeutic effects in cancer using 
1 8F-2-fluoro-2-deoxy-D-glucose and positron emmision tomography: preliminary study of lung 
cancer. Int. J. Rad. One. Biol. Phys., 1990. 19: p. 1005-1010. 
47. Rozenthal, J.M., J.D. Cohen, and M.P. Mehta, Acute changes in glucose uptake after treatment: the 
effects of carmustine (BCNU) on human glioblastoma multiforme. J. Neuro. One., 1993. 15: p. 57-66. 
48. Lexa, F.J., R.l. Grossman, and A.C. Rosenquist, MR of Wallerian degeneration in the feline visual 
system: characterization by magnetization transfer rate with histopathologic correlation. A.J.N.R., 
1994. 15: p. 210-212. 
Recombinant DNA Research, Volume 20 
[373] 
